切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (03) : 178 -182. doi: 10.3877/cma.j.issn.2095-3232.2014.03.012

所属专题: 文献

基础研究

活化态肝星状细胞调控肝细胞癌微血管形成的机制
李龑杼1, 林楠1, 卢逸1, 朱冰1, 许瑞云1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝胆外科
  • 收稿日期:2014-03-07 出版日期:2014-06-10
  • 通信作者: 许瑞云
  • 基金资助:
    国家自然科学基金(81272642)

Regulatory mechanism of activated hepatic stellate cell in the microvascular generation of hepatocellular carcinoma

Yanzhu Li1, Nan Lin1, Yi Lu1, Bing Zhu1, Ruiyun Xu1,()   

  1. 1. Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2014-03-07 Published:2014-06-10
  • Corresponding author: Ruiyun Xu
  • About author:
    Corresponding author: Xu Ruiyun, Email:
引用本文:

李龑杼, 林楠, 卢逸, 朱冰, 许瑞云. 活化态肝星状细胞调控肝细胞癌微血管形成的机制[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(03): 178-182.

Yanzhu Li, Nan Lin, Yi Lu, Bing Zhu, Ruiyun Xu. Regulatory mechanism of activated hepatic stellate cell in the microvascular generation of hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(03): 178-182.

目的

探讨活化态肝星状细胞(aHSC)调控肝细胞癌(肝癌)微血管形成的机制。

方法

组织标本来源于2013年1月至12月在中山大学附属第三医院肝胆外科行肝切除术的25例肝癌患者。所有患者均签署知情同意书,符合医学伦理学规定。其中男21例,女4例;年龄29~75岁,中位年龄54岁。分别取肝癌组织(肝癌组)、癌旁组织(癌旁组),同时选取21例正常肝组织作对照组。免疫组织化学方法(免疫组化法)检测平滑肌肌动蛋白(SMA)、血管生成素(Ang) -1、分化群(CD)34表达。蛋白质印迹法(Western blot)检测Ang-1表达水平。肝癌组织SMA高表达为aHSC的标志。3组比较采用单因素方差分析和LSD-t检验。蛋白表达的相关性采用Spearman相关分析。

结果

肝癌组、癌旁组和对照组SMA平均光密度值分别为(4.56±0.64)×104、(2.71±0.37)×104、(2.25±0.48)×104,肝癌组明显高于癌旁组和对照组(LSD-t=7.09,7.42;P<0.05)。3组Ang-1光密度值分别为(3.11±0.27)×105、(2.28±0.20)×105、(1.26±0.15)×105,肝癌组明显高于癌旁组和对照组(LSD-t=3.00,3.14;P<0.05)。3组Ang-1表达相对灰度值分别4.33±1.17、1.62±0.33、1.60±0.38,肝癌组明显高于癌旁组和对照组(LSD-t=2.71,2.74;P<0.05)。3组CD34光密度值分别为(18.30±0.36)×103、(5.75±1.17)×103、(2.75±0.72)×103,肝癌组明显高于癌旁组和对照组(LSD-t=3.21,3.36;P<0.05)。SMA与Ang-1、CD34,Ang-1与CD34两两之间均呈正相关(r= 0.442,0.449,0.582;P<0.05)。

结论

肝癌组织中SMA、Ang-1、CD34呈高表达,且三者密切相关。肝癌组织中存在SMA标记的aHSC,aHSC可能通过分泌Ang-1促进肝癌微血管形成。

Objective

To investigate the regulatory mechanism of activated hepatic stellate cell (aHSC) in the microvascular generation of hepatocellular carcinoma (HCC).

Methods

Tissue samples of 25 patients with HCC who underwent liver resection in Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University from January to December 2013 were collected. The informed consents of all patients were obtained and the ethical committee approval was received. There were 21 males and 4 females with age ranging from 29 to 75 years old and the median age of 54 years old. The HCC tissues (HCC group) and peri-cancer tissues (peri-cancer group) were collected and normal liver tissues of 21 cases were collected as control group. The expressions of smooth muscle actin (SMA), angiogenin (Ang-1), and cluster of differentiation (CD) 34 were detected by immunohistochemistry. The expression level of Ang-1 was detected by Western blot. The high expression of SMA in HCC tissues was regarded as a marker of aHSC. The differences of 3 groups were compared using one-way analysis of variance and LSD-t test. Spearman correlation analysis was used to analyze the correlations between different proteins expression.

Results

The mean of optical densities of SMA in HCC, peri-cancer, control group were (4.56±0.64)×104, (2.71±0.37)×104, (2.25±0.48)×104 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=7.09, 7.42; P<0.05). The optical densities of Ang-1 in 3 groups were (3.11±0.27)×105, (2.28±0.20)×105, (1.26±0.15)×105 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=3.00, 3.14; P<0.05). The relative gray values of Ang-1 expression in 3 groups were 4.33±1.17, 1.62±0.33, 1.60±0.38 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=2.71, 2.74; P<0.05). The optical intensities of CD34 in 3 groups were (18.3±0.36)×103, (5.75±1.17)×103, (2.75±0.72)×103 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=3.21, 3.36; P<0.05). There were positive correlations between SMA, Ang-1, CD34 (r=0.442, 0.449, 0.582; P<0.05).

Conclusions

High expressions of SMA, Ang-1 and CD34 can be observed in HCC group and closely related with each other. SMA marked aHSC can be observed in the HCC tissues. The aHSC may promote the microvascular generation of HCC by secreting Ang-1.

图1 三组组织中平滑肌肌动蛋白的表达
图2 三组组织中血管生成素-1的表达
图3 三组组织中分化群34的表达
[1]
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
[2]
Jia YL, Shi L, Zhou JN, et al. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focaladhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis[J]. Hepatology, 2011, 54(5):1808-1818.
[3]
Sancho-Bru P, Juez E, Moreno M, et al. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepaticstellate cells[J]. Liver Int, 2010, 30(1):31-41.
[4]
陈之巨,林楠,潘楚芝,等.活化态肝星状细胞对小鼠肝细胞肝癌血管形成、肿瘤生长及转移的作用[J/CD].中华肝脏外科手术学电子杂志,2013, 2(3):186-193.
[5]
Fernández M, Semela D, Bruix J, et al. Angiogenesis in liver disease[J]. J Hepatol, 2009, 50(3):604-620.
[6]
Sancho-Bru P, Juez E, Moreno M, et al. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepaticstellate cells[J]. Liver Int, 2010, 30(1):31-41.
[7]
Folkman J. Angiogenesis: an organizing principle for drug discovery? [J]. Nat Rev Drug Discov, 2007, 6(4):273-286.
[8]
Holopainen T, Huang H, Chen C, et al. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination andmetastasis establishment[J]. Cancer Res, 2009, 69(11):4656-4664.
[9]
Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system[J]. Nat Rev Mol Cell Biol, 2009, 10(3):165-177.
[10]
Ji Y, Wang Z, Li Z, et al. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells[J]. Cell Physiol Biochem, 2012, 29(5/6):863-874.
[11]
Huang H, Bhat A, Woodnutt G, et al. Targeting the ANGPT-TIE2 pathway in malignancy[J]. Nat Rev Cancer, 2010, 10(8):575-585.
[12]
Torimura T, Ueno T, Kin M, et al. Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma[J]. J Hepatol, 2004, 40(5):799-807.
[13]
Thomas M, Augustin HG. The role of the angiopoietins in vascular morphogenesis[J]. Angiogenesis, 2009, 12(2):125-137.
[14]
Huang J, Bae JO, Tsai JP, et al. Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade[J]. Int J Oncol, 2009, 34(1):79-87.
[15]
Holopainen T, Huang H, Chen C, et al. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment[J]. Cancer Res, 2009, 69(11):4656-4664.
[16]
Stoeltzing O, Ahmad SA, Liu W, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors[J]. Cancer Res, 2003, 63(12):3370-3377.
[17]
Taura K, De Minicis S, Seki E, et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis[J]. Gastroenterology, 2008, 135(5):1729-1738.
[1] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[6] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[7] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[8] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[11] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[12] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[13] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[14] 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 407-449.
[15] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?